JP2022529996A5 - - Google Patents

Info

Publication number
JP2022529996A5
JP2022529996A5 JP2021562350A JP2021562350A JP2022529996A5 JP 2022529996 A5 JP2022529996 A5 JP 2022529996A5 JP 2021562350 A JP2021562350 A JP 2021562350A JP 2021562350 A JP2021562350 A JP 2021562350A JP 2022529996 A5 JP2022529996 A5 JP 2022529996A5
Authority
JP
Japan
Prior art keywords
composition according
pvp
antibody
composition
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562350A
Other languages
English (en)
Japanese (ja)
Other versions
JP7739182B2 (ja
JP2022529996A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029328 external-priority patent/WO2020219550A1/en
Publication of JP2022529996A publication Critical patent/JP2022529996A/ja
Publication of JP2022529996A5 publication Critical patent/JP2022529996A5/ja
Application granted granted Critical
Publication of JP7739182B2 publication Critical patent/JP7739182B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562350A 2019-04-23 2020-04-22 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用 Active JP7739182B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962837647P 2019-04-23 2019-04-23
US62/837,647 2019-04-23
PCT/US2020/029328 WO2020219550A1 (en) 2019-04-23 2020-04-22 The use of low molecular weight polyvinylpyrrolidone (pvp) to reduce viscosity of high concentration protein formulations

Publications (3)

Publication Number Publication Date
JP2022529996A JP2022529996A (ja) 2022-06-27
JP2022529996A5 true JP2022529996A5 (cg-RX-API-DMAC7.html) 2023-05-01
JP7739182B2 JP7739182B2 (ja) 2025-09-16

Family

ID=70614677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562350A Active JP7739182B2 (ja) 2019-04-23 2020-04-22 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用

Country Status (8)

Country Link
US (1) US12599669B2 (cg-RX-API-DMAC7.html)
EP (1) EP3958840A1 (cg-RX-API-DMAC7.html)
JP (1) JP7739182B2 (cg-RX-API-DMAC7.html)
CN (1) CN113660927A (cg-RX-API-DMAC7.html)
AU (1) AU2020263318B2 (cg-RX-API-DMAC7.html)
CA (1) CA3141857A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021012782A (cg-RX-API-DMAC7.html)
WO (1) WO2020219550A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK4364724T3 (da) 2018-05-10 2025-12-22 Regeneron Pharma Formuleringer med høj koncentration af VEGF-receptorfusionsprotein
WO2022217021A1 (en) * 2021-04-09 2022-10-13 Avantor Performance Materials, Llc Performance-enhancing excipients and methods of reducing viscosity and increasing stability of biologic formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
US6992066B2 (en) 1998-10-16 2006-01-31 Zimmer Orthobiologics, Inc. Povidone-containing carriers for polypeptide growth factors
US20080026068A1 (en) 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20050152980A1 (en) 2002-03-13 2005-07-14 Michael Ausborn Pharmeutical microparticles
CN105833254A (zh) 2008-12-10 2016-08-10 阿勒根公司 梭菌毒素药物组合物
EA201391489A1 (ru) * 2011-04-07 2014-02-28 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Композиции со сниженной вязкостью
US10646574B2 (en) 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
WO2016065181A1 (en) * 2014-10-23 2016-04-28 Amgen Inc. Reducing viscosity of pharmaceutical formulations
JP7377596B2 (ja) * 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
WO2018201064A1 (en) * 2017-04-28 2018-11-01 Amgen Inc. N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides

Similar Documents

Publication Publication Date Title
CN114452380B (zh) Il-17抗体的药物产品和稳定液体组合物
CN110404066B (zh) 一种抗人pd-1的单克隆抗体制剂、联合用药物及其用途
CN104736175B (zh) 抗催乳素受体抗体制剂
TWI375566B (en) High concentration antibody-containing liquid formulation
JP2020518598A5 (cg-RX-API-DMAC7.html)
JP2021515566A5 (cg-RX-API-DMAC7.html)
TWI904081B (zh) 治療多發性骨髓瘤的方法
TW201806617A (zh) 穩定之液體醫藥調配物
JP2021521205A5 (cg-RX-API-DMAC7.html)
CN106474470A (zh) 一种抗il‑17a抗体的组合物
JP2024506940A5 (cg-RX-API-DMAC7.html)
JP2023501377A (ja) 高濃度抗ｃ５抗体配合物
JP2022529996A5 (cg-RX-API-DMAC7.html)
WO2021249445A1 (zh) 抗il-17a抗体药物组合物及其用途
TW202034901A (zh) 抗體配方
JP2005532395A (ja) 新規な安定処方
KR20220140772A (ko) 인간 항-tslp 항체 제형 및 염증성 질환의 치료 방법
JP7755766B2 (ja) 抗ｉｌ－６抗体製剤
JP2021518348A5 (cg-RX-API-DMAC7.html)
JP7739182B2 (ja) 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用
CN111683681B (zh) 包含抗ox40抗体的制剂、其制备方法及其用途
JP2022518441A5 (cg-RX-API-DMAC7.html)
CN113698478B (zh) 抗α-溶血素的抗体及其稳定制剂
RU2745814C1 (ru) Водная фармацевтическая композиция левилимаба и ее применение
CN116172947A (zh) 一种含特异性结合vegf和ang2的双特异性抗体的药物组合物